Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satyendra Suryawanshi

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Paediatric Drugs|February 14, 2020
Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric PatientsZaid H Temrikar, Satyendra Suryawanshi, Bernd Meibohm
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 18, 2007
Simultaneous estimation of mangiferin and four secoiridoid glycosides in rat plasma using liquid chromatography tandem mass spectrometry and its application to pharmacokinetic study of herbal preparationSatyendra Suryawanshi, R K Asthana, R C Gupta
The AAPS Journal|February 28, 2018
Reporting, Visualization, and Modeling of Immunogenicity Data to Assess Its Impact on Pharmacokinetics, Efficacy, and Safety of Monoclonal AntibodiesChaitali Passey, Satyendra Suryawanshi, Kinjal Sanghavi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 18, 2005
A sensitive and selective HPLC/ESI-MS/MS assay for the simultaneous quantification of 16-dehydropregnenolone and its major metabolites in rabbit plasmaSatyendra Suryawanshi, S K Singh, R C Gupta
Phytotherapy Research : PTR|January 14, 2009
Assessment of systemic interaction between Swertia chirata extract and its Bioactive constituents in rabbitsSatyendra Suryawanshi, R K Asthana, R C Gupta
Expert Opinion on Drug Discovery|July 25, 2012
The current role of model-based drug developmentSatyendra Suryawanshi, Liping Zhang, Marc Pfister, et al.
British Journal of Clinical Pharmacology|May 30, 2019
Evaluation of covariate effects on pharmacokinetics of monoclonal antibodies in oncologyGaurav Bajaj, Satyendra Suryawanshi, Amit Roy, et al.
The Journal of Pharmacy and Pharmacology|December 16, 2010
Preclinical pharmacokinetics, dose proportionality, gender difference and protein binding study of 16-dehydropregnenolone, an antihyperlipidemic agent, in ratsSatyendra Suryawanshi, Wahajuddin, Ram Chandra Gupta, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 24, 2019
Linking Tumor Growth Dynamics to Survival in Ipilimumab-Treated Patients With Advanced Melanoma Using Mixture Tumor Growth Dynamic ModelingYan Feng, Xiaoning Wang, Satyendra Suryawanshi, et al.
Rapid Communications in Mass Spectrometry : RCM|November 23, 2006
Liquid chromatography/tandem mass spectrometric study and analysis of xanthone and secoiridoid glycoside composition of Swertia chirata, a potent antidiabeticSatyendra Suryawanshi, Nitin Mehrotra, R K Asthana, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Paediatric Drugs|February 14, 2020
Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric PatientsZaid H Temrikar, Satyendra Suryawanshi, Bernd Meibohm
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 18, 2007
Simultaneous estimation of mangiferin and four secoiridoid glycosides in rat plasma using liquid chromatography tandem mass spectrometry and its application to pharmacokinetic study of herbal preparationSatyendra Suryawanshi, R K Asthana, R C Gupta
The AAPS Journal|February 28, 2018
Reporting, Visualization, and Modeling of Immunogenicity Data to Assess Its Impact on Pharmacokinetics, Efficacy, and Safety of Monoclonal AntibodiesChaitali Passey, Satyendra Suryawanshi, Kinjal Sanghavi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 18, 2005
A sensitive and selective HPLC/ESI-MS/MS assay for the simultaneous quantification of 16-dehydropregnenolone and its major metabolites in rabbit plasmaSatyendra Suryawanshi, S K Singh, R C Gupta
Phytotherapy Research : PTR|January 14, 2009
Assessment of systemic interaction between Swertia chirata extract and its Bioactive constituents in rabbitsSatyendra Suryawanshi, R K Asthana, R C Gupta
Expert Opinion on Drug Discovery|July 25, 2012
The current role of model-based drug developmentSatyendra Suryawanshi, Liping Zhang, Marc Pfister, et al.
British Journal of Clinical Pharmacology|May 30, 2019
Evaluation of covariate effects on pharmacokinetics of monoclonal antibodies in oncologyGaurav Bajaj, Satyendra Suryawanshi, Amit Roy, et al.
The Journal of Pharmacy and Pharmacology|December 16, 2010
Preclinical pharmacokinetics, dose proportionality, gender difference and protein binding study of 16-dehydropregnenolone, an antihyperlipidemic agent, in ratsSatyendra Suryawanshi, Wahajuddin, Ram Chandra Gupta, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 24, 2019
Linking Tumor Growth Dynamics to Survival in Ipilimumab-Treated Patients With Advanced Melanoma Using Mixture Tumor Growth Dynamic ModelingYan Feng, Xiaoning Wang, Satyendra Suryawanshi, et al.
Rapid Communications in Mass Spectrometry : RCM|November 23, 2006
Liquid chromatography/tandem mass spectrometric study and analysis of xanthone and secoiridoid glycoside composition of Swertia chirata, a potent antidiabeticSatyendra Suryawanshi, Nitin Mehrotra, R K Asthana, et al.
Pageof 3